Skystar bio-pharmaceutical gains exclusive rights to sell and market aquaculture vaccine through 2024
Skystar Bio-Pharmaceutical Company, a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it has gained exclusive rights to sell and market its aquaculture vaccine through 2024.
Novartis AG has bought worldwide rights to a new antibiotic drug developed by US company Paratek Pharmaceuticals to treat drug-resistant bacteria such as MRSA.